Scientists map immune defenses in ovarian cancer
NCT ID NCT05984875
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the immune system in women with a new diagnosis of epithelial ovarian cancer. Researchers will collect tumor tissue, blood, and other samples to see how different immune cells relate to how long patients stay cancer-free. The goal is to learn more, not to test a new treatment. About 74 women will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPITHELIAL OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Oncology Institute of Southern Switzerland
RECRUITINGBellinzona, 6500, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Metabolic clues: could your Body's energy use predict ovarian cancer outcomes?
- Can heated chemo during surgery help older women with ovarian cancer?
- Can a custom mRNA vaccine keep ovarian cancer from coming back?
- Could centralized surgery boost ovarian cancer survival?
- Targeted drug hunts down cancer cells in advanced bladder cancer trial
- New PET tracer aims to spot hidden cancer spread in the abdomen